Generation Bio Co. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2019 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Generation Bio Co. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2019 to Q2 2025.
  • Generation Bio Co. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2025 was $1.69M, a 54.2% decline year-over-year.
  • Generation Bio Co. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2025 was $10.6M, a 46.2% decline year-over-year.
  • Generation Bio Co. annual Share-based Payment Arrangement, Expense for 2024 was $14.6M, a 40% decline from 2023.
  • Generation Bio Co. annual Share-based Payment Arrangement, Expense for 2023 was $24.3M, a 0.45% decline from 2022.
  • Generation Bio Co. annual Share-based Payment Arrangement, Expense for 2022 was $24.5M, a 36.9% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 $10.6M $1.69M -$2M -54.2% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-12
Q1 2025 $12.6M $2.01M -$1.99M -49.7% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-07
Q4 2024 $14.6M $3.16M -$2.89M -47.8% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-13
Q3 2024 $17.5M $3.75M -$2.25M -37.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $19.7M $3.7M -$2.33M -38.6% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-12
Q1 2024 $22.1M $4M -$2.27M -36.2% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-07
Q4 2023 $24.3M $6.05M +$201K +3.44% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-13
Q3 2023 $24.1M $6M +$156K +2.67% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 $24M $6.02M -$668K -9.98% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $24.7M $6.27M +$200K +3.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 $24.5M $5.85M +$1.41M +31.7% Oct 1, 2022 Dec 31, 2022 10-K 2025-03-13
Q3 2022 $23M $5.85M +$878K +17.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $22.2M $6.69M +$1.72M +34.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $20.4M $6.07M +$2.59M +74.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $17.9M $4.44M +$1.06M +31.3% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-06
Q3 2021 $16.8M $4.97M +$2.81M +130% Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $14M $4.97M +$3.6M +263% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-03
Q1 2021 $10.4M $3.48M +$1.98M +131% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $8.41M $3.38M Oct 1, 2020 Dec 31, 2020 10-K 2023-02-23
Q3 2020 $2.16M +$1.08M +100% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $1.37M +$319K +30.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 $1.5M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q3 2019 $1.08M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $1.05M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.